IPHA Innate Pharma
- 2.540
- 0.0000.00%
Innate Pharma News
Innate Pharma | 20-F: Registration statement / Annual report / Transition report
Innate Pharma | 6-K: Report of foreign private issuer (related to financial reporting)
Innate Pharma | 6-K: Report of foreign private issuer (related to financial reporting)
Innate Pharma | 6-K: Report of foreign private issuer (related to financial reporting)
Innate Pharma | 6-K: Report of foreign private issuer (related to financial reporting)
Innate Pharma | 6-K: Report of foreign private issuer (related to financial reporting)
Innate Pharma | 6-K: Report of foreign private issuer (related to financial reporting)
Innate Pharma | 6-K: Report of foreign private issuer (related to financial reporting)
Innate Pharma | 6-K: Report of foreign private issuer (related to financial reporting)
Innate Pharma | 6-K: Report of foreign private issuer (related to financial reporting)
Innate Pharma | 6-K: Report of foreign private issuer (related to financial reporting)
Innate Pharma | 20-F/A: Registration statement / Annual report / Transition report (Amendment)
Innate Pharma: FY2022 Annual Report
20-F | Innate Pharma SA (0001598599) (Filer)
Innate Pharma | 6-K: Report of foreign private issuer (related to financial reporting)
Innate Pharma | 6-K: Report of foreign private issuer (related to financial reporting)
Innate Pharma | 6-K: Report of foreign private issuer (related to financial reporting)
Innate Pharma | 6-K: Report of foreign private issuer (related to financial reporting)
Innate Pharma | 6-K: Report of foreign private issuer (related to financial reporting)
Innate Pharma | 6-K: Report of foreign private issuer (related to financial reporting)
Innate Pharma | 6-K: Report of foreign private issuer (related to financial reporting)
Analysis
Price Target
No Data
